Karen Pendergrass, Standards Team

Scoliosis, a spinal curvature over 10°, is influenced by gut microbiome variations, affecting spinal, respiratory, and cardiovascular health.

Routine consumption of hibiscus tea or juice may affect female fertility by disrupting ovulation, implantation, and hormonal balance. Women trying to conceive or undergoing fertility treatments should be cautious and discuss herbal intake with their healthcare provider to avoid unintended reproductive consequences.

Probiotics offer a promising microbiome-targeted intervention (MBTI) for managing pelvic inflammatory disease (PID). By restoring beneficial Lactobacillus species and reducing inflammation, they directly counteract the microbial imbalances and immune dysregulation characteristic of PID. This article explores the therapeutic mechanisms of probiotics, their clinical validation, and how they reinforce the accuracy of PID’s microbiome signature as both a diagnostic and therapeutic tool.

OverviewProbiotics have emerged as a promising microbiome-targeted intervention (MBTI) for vulvovaginal candidiasis (VVC), addressing both microbial imbalances and the host’s immunological and inflammatory mechanisms. By restoring a healthy Lactobacillus-dominated vaginal microbiota, probiotics directly counteract dysbiosis linked to VVC, while their bioactive metabolites such as lactic acid and bacteriocins suppress Candida overgrowth and modulate local immune […]

Excessive zinc intake may worsen endometriosis by activating estrogen receptors, disrupting immune function, and altering the microbiome. A large NHANES study found that intake above 14 mg/day significantly increases endometriosis risk. With many supplements exceeding this threshold, routine zinc supplementation may contribute to disease progression rather than prevention, prompting a Suggested Termination of Practice (STOP).

Tinidazole shows strong alignment with endometriosis microbiome signatures by targeting MMAs such as Prevotella and Fusobacterium. Its pharmacological profile and potential for microbial realignment make it a compelling candidate for fast-tracked translational research and microbiome-targeted intervention.

Synbiotics restore gut microbiome balance in PCOS, improving insulin sensitivity, reducing inflammation, and normalizing androgen levels. This validation reinforces its role as a microbiome-targeted intervention.

Probiotic supplementation addresses microbial dysbiosis and inflammatory processes in PCOS, improving metabolic and hormonal outcomes, thereby validating its role as an MBTI.

Statins target both microbial imbalances and inflammatory mechanisms in PCOS. By improving gut microbial composition and metabolic parameters, statins validate the microbiome signature of PCOS and enhance fertility and metabolic health outcomes.

Resistant dextrin targets both metabolic and microbial imbalances in PCOS. It reduces fasting blood glucose, lipids, and androgens, while improving microbial composition, supporting its role as a microbiome-targeted intervention (MBTI) for PCOS-related infertility and metabolic health.

Metformin targets both the microbiome and inflammatory mechanisms in PCOS, improving insulin sensitivity, reducing hyperandrogenism, and restoring ovulation. Its microbial effects validate the condition’s microbiome signature, making it a promising microbiome-targeted intervention for managing infertility in PCOS.

Prebiotic Maltose Gel has emerged as a promising microbiome-targeted therapy for bacterial vaginosis (BV), restoring vaginal health by selectively enhancing Lactobacillus populations and suppressing BV-associated anaerobes. This dual-action intervention not only validates the gel’s therapeutic efficacy but also confirms the accuracy of BV’s microbiome signature as a clinical marker.

Probiotic interventions, particularly those involving Lactobacillus crispatus and Saccharomyces cerevisiae, restore balance to the vaginal microbiome in bacterial vaginosis (BV). By reducing dominant anaerobes like Gardnerella vaginalis and promoting recolonization with protective Lactobacillus, these therapies validate both their role as microbiome-targeted interventions (MBTIs) and the diagnostic accuracy of the BV microbiome signature.

Essential oils (EOs) are emerging as powerful microbiome-targeted interventions for biofilm-associated infections (BAIs). Backed by preclinical evidence, EOs disrupt biofilm formation, reduce inflammation, and restore microbial balance. This validation supports their dual role in treating BAIs and confirming the microbiome signature linked to the condition.

Bovine lactoferrin has emerged as a promising microbiome-targeted intervention (MBTI) for bacterial vaginosis (BV). Clinical and preclinical studies confirm its dual-action ability to restore Lactobacillus dominance and suppress BV-associated pathogens like Gardnerella and Prevotella. These microbial shifts, combined with anti-inflammatory effects, validate both the efficacy of bovine lactoferrin and the diagnostic accuracy of the BV microbiome signature.

Vitamin C vaginal tablets represent a compelling microbiome-based therapy for recurrent bacterial vaginosis. By restoring vaginal pH and supporting Lactobacillus reestablishment, this intervention validates both its therapeutic role and the microbial signature of BV.

Tinidazole is a validated microbiome-targeted therapy for bacterial vaginosis, restoring microbial balance and aligning with diagnostic signatures. It offers better tolerability than metronidazole, with fewer side effects and strong clinical outcomes.

Secnidazole demonstrates dual efficacy in treating bacterial vaginosis by targeting pathogenic anaerobes while preserving beneficial Lactobacillus, validating both its role as a microbiome-based therapeutic intervention (MBTI) and the accuracy of BV’s microbial signature in guiding effective treatment.

Clindamycin is effective in treating bacterial vaginosis by reducing Gardnerella vaginalis and promoting Lactobacillus growth, but recurrence rates highlight the need for adjunct therapies targeting biofilms.

Boric acid restores microbial balance in the vagina by increasing Lactobacillus and reducing harmful species, making it an effective treatment for recurrent BV and VVC.

This review highlights how neurodegenerative diseases like Alzheimer’s disease (AD), Parkinson’s disease (PD), and dementia with Lewy bodies (DLB) exhibit disease-specific metallomic signatures, with copper depletion as a shared feature. Metal imbalances reflect both cause and consequence in neurodegeneration and may offer diagnostic potential when captured through region-specific elemental analysis.

Metronidazole addresses microbial imbalances in bacterial vaginosis by reducing Gardnerella vaginalis and promoting Lactobacillus growth, but biofilm-related resistance may contribute to high recurrence rates. Adjunct therapies are needed for long-term success.

OverviewCurcumin, a polyphenolic compound derived from Curcuma longa, and fecal microbiota transplant (FMT) have shown promise in treating polycystic ovary syndrome (PCOS), a condition often linked with gut dysbiosis. FMT, which restores a balanced microbiome, has been proposed as a strategy to alleviate symptoms of PCOS by modulating microbial composition and reducing inflammation.[1] Curcumin’s anti-inflammatory […]

Cannabidiol (CBD) shows promise as a microbiome-targeted intervention for bacterial vaginosis (BV). It reduces Gardnerella vaginalis viability, disrupts biofilms, and promotes Lactobacillus restoration. CBD’s antimicrobial, anti-inflammatory, and antioxidant properties support its effectiveness, reinforcing the BV microbiome signature’s clinical accuracy and its potential as a viable treatment option.